Digitisation | August 11, 2021
Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment
The aim is to create new genomics solutions that could combat cancer and advance market access
The aim is to create new genomics solutions that could combat cancer and advance market access
Forex gains stood at Rs 20 crore for the quarter
The company has been consistently reducing debt
Total income grew in the quarter
Dr. Reddy's has the rights to distribute 250mn doses in India
The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India
Vivimed strategy is to increase its share of Branded products in CIS Markets.
One task, one interaction, one pair, experts advocate
The first of four planned modules at the new plant is expected to come online by summer 2026
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Subscribe To Our Newsletter & Stay Updated
